Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top therapeutic classes by global pharmaceutical sales 2018 estimates

Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)

by Matej Mikulic, last edited Jun 4, 2019
Top therapeutic classes by global pharmaceutical sales 2018 estimates This statistic depicts the top 10 therapeutic classes by global pharmaceutical sales in 2018. In that year, the global pharmaceutical industry is estimated to generate a total revenue of some 36 billion U.S. dollars through mental health drug spending.
Top therapeutic classes and drugs

Oncologics, pain therapy, and anti-diabetics are among the top global pharmaceuticals based on revenues, generating some 100 billion U.S. dollars, 79 billion U.S. dollars, and 40 billion U.S. dollars, respectively, in 2018. In oncologic developments, drugs for non-small cell lung cancer and breast cancer were among the leading diseases in therapeutic drug development. On the other hand, mental health drugs like Cymbalta generated about 36 billion dollars of revenue worldwide. Cymbalta is manufactured by Eli Lilly and used to treat major depressive disorder and generalized anxiety disorder.

One of Bristol-Myers Squibb’s most profitable medications was Abilify, a neurology product that generated revenue of 5.8 billion U.S. dollars in the United States in 2015. Aripiprazole, marketed as Abilify, is used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, among other disorders. Bristol-Myers Squibb’s neuroscience program focuses on the development of therapeutic regimens for disorders that impact the brain and nervous systems. Some of the company’s other therapeutic areas of focus include cardiovascular, immunoscience, and virology.
Show more

Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Top pharmaceutical drugs
Top pharmaceutical drugs

All Information
in one Presentation

Top pharmaceutical drugs

Everything On "Top pharmaceutical drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Global pharmaceutical industry"
  • Overview
The most important statistics
  • Companies and products
  • Top companies by revenue
  • R&D, patents, new products
  • Outlook
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.